Immune globulins and thrombotic adverse events as recorded in a large administrative database in 2008 through 2010

Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study

(2011) Sreeram V Ramagopalan et al.   BMC Medicine

Slow and steady. Reducing thrombotic events in renal transplant recipients treated with IVIg for antibody-mediated rejection

(2011) LOUIS HUANG et al.   NEPHROLOGY

The New Generation of Liquid Intravenous Immunoglobulin Formulations in Patient Care: A Comparison of Intravenous Immunoglobulins

(2011) Mark R. Stein   POSTGRADUATE MEDICINE

Identification of kallikrein and FXIa as impurities in therapeutic immunoglobulins: implications for the safety and control of intravenous blood products

(2011) M. Etscheid et al.   VOX SANGUINIS

Use of intravenous immune globulin in the ICU: a retrospective review of prescribing practices and patient outcomes

(2010) R. Foster et al.   TRANSFUSION MEDICINE

Case-control study of thromboembolic events associated with IV immunoglobulin

(2009) J. B. Caress et al.   JOURNAL OF NEUROLOGY

Unlabeled uses of intravenous immune globulin

(2008) H. Leong et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

The Estimation Power of Alternative Comorbidity Indices

(2008) Onur Baser et al.   VALUE IN HEALTH